• In early April 2026, Synchrony Financial expanded its product reach by launching a new RH Credit Card for luxury home furnishings brand RH and enabling CareCredit cardholders to use their cards for a wider range of eligible health and wellness purchases on Walmart.com.
• Together, these moves highlight how Synchrony is deepening its role in high-end home décor and everyday health spending through tailored financing and broader online acceptance.
• We’ll now explore how the expanded CareCredit acceptance on Walmart.com could influence Synchrony’s existing investment narrative around partnerships and digital growth.

Rare earth metals are the new gold rush. Find out which 31 stocks are leading the charge.

Synchrony Financial Investment Narrative Recap

To own Synchrony, you generally need to believe that its partner-centric model can still grow in a world of tighter credit, rising regulation, and fast-changing digital payments. The Walmart.com CareCredit expansion nudges the near term catalyst of digital and embedded finance growth in the right direction, but it does not remove key risks around partner concentration, elevated payment rates, or competitive pressure from newer financing options.

The CareCredit expansion on Walmart.com is especially relevant here because it reinforces one of the clearest existing catalysts: deeper digital integration with major omnichannel retailers. By making CareCredit usable across more online health, fitness, and sleep categories, Synchrony is extending its health and wellness footprint in a way that aligns with its broader push into high growth verticals and embedded finance, while testing how much incremental purchase volume these partnerships can actually support.

Yet, even as CareCredit grows on Walmart.com, investors should be aware that concentrated reliance on a few major partners could...

Synchrony Financial's narrative projects $16.5 billion revenue and $3.3 billion earnings by 2028. This requires 21.7% yearly revenue growth and a modest $0.1 billion earnings increase from $3.2 billion today.

Uncover how Synchrony Financial's forecasts yield a $90.26 fair value, a 15% upside to its current price.

Exploring Other Perspectives

Compared with the baseline view, the most optimistic analysts paint a much stronger growth story, expecting revenue to reach about US$18.2 billion and earnings around US$3.4 billion before this Walmart and RH news, so if you are weighing that upbeat outlook against concerns about traditional store cards and new financing models, it is worth exploring how these fresh announcements might shift both the potential and the risks.

Explore 7 other fair value estimates on Synchrony Financial - why the stock might be worth over 2x more than the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Synchrony Financial research is our analysis highlighting 5 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Synchrony Financial research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Synchrony Financial's overall financial health at a glance.

Want Some Alternatives?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

• Outshine the giants: these 19 early-stage AI stocks could fund your retirement.
• AI is about to change healthcare. These 36 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• The future of work is here. Discover the 34 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.